Columbia University
Mission Statement
We provide over 70 different services and programs focused on education and training, seed funding, bioinformatics, biostatistics, clinical research, lifespan research and special populations, regulatory knowledge and bioethics, an off-site community facility and health informatics websites.
At a Glance
2
Educational Resources Posted
8
Consortium News Stories Posted
1
Events Posted
1
Opportunities Posted
396
Publications citing CTSA Program Grant
52
Users from Hub Registered
UL1 Award
KL2 Award
TL1 Award
UL1
UL1 Director
MuredachReillyHerbert and Florence Irving Professor of Medicine; Director and PI, Irving Institute for Clinical and Translational Research, Associate Dean for Clinical and Translational Research, Columbia UniversityUL1 Administrator
,
MichelleMcClaveAssociate Director for Programs and CommunicationEducation
Education Contact
KL2 Director
,
JeanineGenkingerAssociate Professor, Department of EpidemiologyKL2 Administrator
TL1 Director
,TL1 Administrator
Communications
Communications Representative
Enterprise Committees
Integration Across Lifespan Voting Member
KarenMarderSally Kerlin Professor of Neurology (in the Sergievsky Center, Taub Institute, and Psychiatry)Methods and Processes Voting Member
HaroldPincusProfessor and Vice Chair Psychiatry, Co-Director Irving Institute/CTSAWorkforce Development Voting Member
Informatics Voting Member
Collaboration and Engagement Voting Member
Common Metrics
Primary CM Contact
Additional CM Contacts
HaroldPincusProfessor and Vice Chair Psychiatry, Co-Director Irving Institute/CTSA
ElisabethDiMariaAssistant Director for Interdisciplinary Initiatives and Operations-
JeanineGenkingerAssociate Professor, Department of Epidemiology
-
SudhaKashyapProfessor of Pediatrics at Columbia University Medical Center
-
KarenMarderSally Kerlin Professor of Neurology (in the Sergievsky Center, Taub Institute, and Psychiatry)
-
MichelleMcClaveAssociate Director for Programs and Communication
-
AkivaMintzProfessor, Director of Pilots and Collaborative Studies Resource (PCSR) and Translational Therapeutics Accelerator (TRx)
-
DaniellePendrickAssociate Director, Columbia University Biobank
-
HaroldPincusProfessor and Vice Chair Psychiatry, Co-Director Irving Institute/CTSA
-
MariaRahmanySr.Business Development Officer and Program Manager
-
MuredachReillyHerbert and Florence Irving Professor of Medicine; Director and PI, Irving Institute for Clinical and Translational Research, Associate Dean for Clinical and Translational Research, Columbia University
JacquelynTaylorEndowed Professor of Nursing and Founding Executive Director of the Center for Research on People of Color
RonaldWapnerProfessor of Obstertrics and Gynecology; Vice Chair of Research; Director of Reproductive Genetics
Consortium News
The grant, awarded by the National Institutes of Health, is one of the largest ever to the medical school. It will support the work of the Irving Institute for Clinical and Translational Research, led by Muredach Reilly, MBBCh, MSCE, professor of medicine and associate dean for clinical and translational research. The Institute works in partnership with researchers and clinicians across Columbia
A discussion with Andrea Califano and narrative medicine writer, Rita Charon: Art and science unfold in time as chronological sightings overturn until-then received knowledge—from the epic to the novel, from classical portraiture to cubism, from before Copernicus to after Copernicus. Art and science unfold in space as discoverers choose a scale and a scope—from parole to langue, from harmony to
The Irving Institute for Clinical and Translational Research, Columbia University's CTSA Hub, has partnered with Rita Charon on a new narrative medicine series, interviewing today’s leading life scientists. "The effective practice of medicine requires narrative competence, that is, the ability to acknowledge, absorb, interpret, and act on the stories and plights of others. Medicine practiced with
Educational Content
This course has been recorded and the full video series is now available online. Taught via Zoom at Columbia University, Fall 2020. Intellectual property (patents, copyrights, trademarks) are an increasingly critical part of almost any business, at almost any stage of growth. This course provides the aspiring business executive, entrepreneur, or scientist an overview of commercial opportunities
Events
These stand-alone workshops precede the May 6th-7th conference for best practices in representation & reasoning. The workshops have separate calls for papers and their own program and organizing committee. The tutorials are half-day learning sessions that include both lecture style and hands-on sessions. Early bird registration ends Feb 15, 2020!
Opportunities
The Irving Institute for Clinical and Translational Research, home of the Columbia University CTSA Hub, is offering - TL1 Training Program Now Accepting Applications The TL1 Training Programs are intended to provide trainees with additional research training to prepare for a research career that can contribute in some meaningful way to understanding risk of disease, improving diagnosis and
Poster Sessions
The Irving Institute for Clinical and Translational Research (IICTR), home to Columbia University’s CTSA Program Hub, supports a mission of bringing novel innovations to patients through education, mentorship and pilot award funding through the Accelerate program. The Accelerate program leverages Columbia University’s proficiency in drug discovery and provides access to entrepreneurs and industry
The Irving Institute for Clinical and Translational Research, home to Columbia University’s CTSA Program Hub, provides resources to investigators in the areas of precision medicine and translational research through two unique resources focused on providing funding, education, research services, and mentorship programs to support advancement of projects. The Translational Therapeutics (TRx)
Publications
Group-randomized trial of tailored brief shared decision-making to improve asthma control in urban black adults
To assess the intervention effects of BREATHE (BRief intervention to Evaluate Asthma THErapy), a novel brief shared decision-making intervention and evaluate feasibility and acceptability of intervention procedures. Group-randomized longitudinal pilot study. In total, 80 adults with uncontrolled
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion
MicroRNAs (miRs) have been shown to play an important role in tumorigenesis, including in head and neck squamous cell carcinoma (HNSCC). The miR-34 family is thought to play a role in tumor suppression, but the exact mechanism of their action in HNSCC is not well understood. Moreover, the impact of
Research and Operational Tools
Learning the Ropes - Irving Institute’s Translational Therapeutics Accelerator (TRx) Helps Researchers Navigate the Challenges of Commercialization